Skip to content

S. 2456 · 118th Congress (2023–2025)

Protecting Seniors from High Drug Costs Act

This bill limits cost-sharing for covered drugs under the Medicare prescription drug benefit to the negotiated price of the drug, net any manufacturer price concessions. Prescription drug plan sponsors are subject to civil penalties for violations.

Show official title

A bill to amend title XVIII of the Social Security Act to limit beneficiary cost-sharing to the net price of covered part D drugs.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 2456’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Jr. Casey Robert P. (D-PA)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Sen. John Cornyn (R-TX)· Original · Jul 20, 2023
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Finance.

    Sources
  3. Expired

    Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.

Committees

  1. SenateFinanceReferred Jul 20, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (2)
  1. Protecting Seniors from High Drug Costs Act

    Display title, Short title · Introduced in Senate

  2. A bill to amend title XVIII of the Social Security Act to limit beneficiary cost-sharing to the net price of covered part D drugs.

    Official title · Introduced in Senate